Croda Share Discussion Threads

[essentialinvestor] 01/11/2012 08:40

This had been priced for perfection.

[broadwood] 12/10/2012 07:26

Obviously leaked yesterday, but love it all the same.


Goldman Sachs Croda... 12/10/12 07:22 Upgrades Buy Conviction Buy 0 3,340.00 -3340 2

[rafieh] 09/10/2012 14:09

A nice day-reversal would mark the end of the profit taking. Next stop £24.

[miata] 09/10/2012 11:49

"Simple profit-taking could be one reason for Croda's decline. Even with the recent fall, this share has gained 28% since the start of the year. Loyal investors will not be worrying too much either, as the price has advanced six-fold since late 2008 and 11-fold since early 2003. July's half-year results showed both earnings and the dividend up 8%."

[kilgallp] 09/10/2012 11:14

Apolgies to all holders, my adding to my holding late on Friday, appears to have triggered a negative reactionj. I suppose I should be used to it by now!

[miata] 02/10/2012 17:19

Curiously the recommendation before was:

Canaccord Genuity Raises Croda International to Sell (CRDA)
September 4th, 2012 - 0 comments - Filed Under - by Jeff Wilder
Croda International (LON: CRDA) was upgraded by research analysts at Canaccord Genuity to a "sell" rating in a report released on Tuesday. The firm currently has a $30.16 (1900 GBX) target price on the stock.

[alphahunter] 02/10/2012 16:57

The link above:

"Croda International (LON: CRDA) was upgraded by equities researchers at Canaccord Genuity to a "sell" ".

I suppose the recommendation before was "give away".

[miata] 02/10/2012 14:30

02 Oct Croda... CRDA Deutsche Bank Buy 2,448.00 2,501.00 2,750.00 2,750.00 Retains

02 Oct Croda... CRDA Canaccord Genuity Sell 2,448.00 2,501.00 1,900.00 1,900.00 Reiterates

[alphahunter] 02/10/2012 14:03

Oct 2, 2012 11:22 AM GMT

BASF SE (BAS) named a new head for its European personal-care chemical business as it hones the unit's focus after a disappointing set of results from additives and ingredients used in cosmetics.

Jan-Peter Sander will take up the role of senior vice president of personal care in Europe on Oct. 1, succeeding Simon Medley, who is leaving to "pursue his career outside the group," Ludwigshafen, Germany-based BASF said in a statement.

BASF is seeking more synergies and cost savings from its integration with Cognis after a dip in performance at its care- chemicals business, Chief Executive Officer Kurt Bock said July 26. BASF paid $3.8 billion for Cognis, which was folded into BASF's care chemicals division that saw a decline in second- quarter sales and earnings.

"We will continue to establish BASF as the market-leading supplier to the personal care industry by focusing on anticipating customers' current and future requirements and providing the market with innovation-driven solutions," Sander said today in the release.

BASF did a "very detailed" study into whether it may be losing market share to competitor Croda International Plc (CRDA), though there was no evidence of this happening, Bock said in July.

[broadwood] 01/10/2012 10:28

Market seems to be anticipating the growth is continuing.

Here's what they said in June. I particularly like the high margins.

The acquisition of IRB is an important strategic step and follows our commitment to look for leading edge technologies and R&D capabilities that will accelerate growth in our core business.
Croda's resilient track record of growth rests on our consistent ability to bring innovative, high margin products to market and expand our presence in emerging economies. Assuming no significant change in market conditions in the near term, we remain confident that this strategy will enable us to make further progress in the second half of 2012."

[miata] 28/9/2012 09:28

Usually last Thursday in October, ie 25/10/12.

[broadwood] 28/9/2012 09:03

Approaching all time highs again - phenomenal stock.Trading statement towards the end of next month on past history.

[miata] 26/7/2012 11:18

Date Broker name New Price Old price target New price target Broker change
25-Jul-12 UBS Neutral 2,358.00p 2,300.00p 2,325.00p Reiteration
24-Jul-12 Liberum Capital Buy 2,364.00p - - Reiteration
11-Jul-12 UBS Neutral 2,253.00p 2,280.00p 2,300.00p DownGrade
26-Jun-12 JP Morgan Cazenove Overweight 2,183.00p 2,200.00p 2,600.00p Upgrade

[broadwood] 25/7/2012 20:28

LONDON (SHARECAST) - It took a while for the market to fully digest the results from speciality chemicals producer Croda International, but once it did the shares raced ahead.

Strong demand for the group's products in the USA offset weaker trading conditions in Europe, while a change in the product mix sold led to an improvement in margins.

[broadwood] 25/7/2012 07:47

I suspect there's more positive price action - not much of a fan of Questor.He usually misses the boat.

There could be a mild retrace though - after yesterdays storming gains.



LONDON (SHARECAST) - In the Telegraph, Croda, the speciality chemicals firm is given high praise for its technology driven sales offering, which includes ingredients for use in lipstick and other cosmetics. The firm's shares trade on nearly 18 times earnings, which is high, and 'given the backdrop', the recommendation is hold

[broadwood] 25/7/2012 07:35

TP increased.


Deutsche Bank Croda... 25/07/12 07:22 Retains Buy Buy 0 2,500.00 2,600.00 100

[scottishfield] 24/7/2012 15:04

No a holder, but good luck to those that are, what a rise today.

[acta_topup] 24/7/2012 13:52

What an amazing chart

[miata] 24/7/2012 13:51

Currently up 7.3% today.

[miata] 24/7/2012 09:53

Interim dividend increased by 8.1% to 26.75p per share.

The interim dividend will be paid on 4 October 2012 to shareholders registered on 31 August 2012.

[miata] 24/7/2012 09:50

Strong demand for its speciality chemicals in America offset weaker trading conditions in Europe for Croda International in the first half of 2012.

Profit before tax in the six months to the end of June rose 6.3% to £132.6m from £124.8m the year before, while in the second quarter alone profit before tax rose 5.3% to £67.5m from £64.1m.

First half sales rose 2.4% to £572.9m from £559.6m in the first half of 2011, while second quarter sales edged up 0.1% to £281.9m from £281.7m a year earlier. Average prices increased by 4.2%, primarily driven by price increases in Europe but also a change in the mix of products being sold.

In the second quarter, the Consumer Care division's sales rose 2.4% to £150.8m from £147.3m the year before, the Performance Technologies division grew sales 0.9% to £105.6m from the preceding year's £104.7m while the group's smallest division, Industrial Chemicals, saw sales tumble 14.1% to £25.5m from £29.7m in the second quarter of 2011. The group noted that the second quarter of 2012 saw fewer trading days in Europe than in the corresponding period of 2011.

Half-year earnings per share rose 8.1% to 66.9p from 61.9p last year, and the interim dividend has been increased in line with earnings growth, to 26.75p from 24.75p.

Net debt at the end of June had been reduced to £208.0m from £253.3m a year earlier as a result of strong free cash flow generation.

"These are a robust set of results which have been achieved despite challenging trading conditions in Europe. Against strong 2011 comparatives and adverse currency translation, both core business segments have made further progress. It is particularly pleasing to see Performance Technologies delivering improved margins and continuing to demonstrate the benefits of increased innovation," said Martin Flower, the Chairman of Croda.

"Assuming no significant change in market conditions in the near term, we remain confident that this strategy will enable us to make further progress in the second half of 2012," Flower added.

[miata] 24/7/2012 09:49

News of results well received today.

[miata] 24/7/2012 09:49

DIVIDENDS Sell on or after the Ex Date and you get the dividend
Announced Type.Div..Ex Date..Pay Date
28/07/11 Int 24.75p 31/08/11 07/10/11
21/02/12 Fin 30.25p 02/05/12 01/06/12
24/07/12 Int 26.75p 29/08/12 04/10/12
26/02/13 Fin 32.75p 01/05/13 31/05/13
23/07/13 Int 29.00p 04/09/13 03/10/13
25/02/14 Fin 35.50p 30/04/14 30/05/14


24 April 2014 Annual General Meeting
24 April 2014 Q1 Interim management statement
30 May 2014 2013 final dividend payment
22 July 2014 Interim results announcement
30 September 2014 2014 Interim dividend payment
6 November 2014 Q3 Interim management statement

[gardenarc] 27/6/2012 09:31

Just added a few .

[shawylove] 22/5/2012 20:31

This share always holds up when the market take a fall, then rises well.